P. A. Dinndorf, J. Gootenberg, M. H. Cohen, P. Keegan, R. Pazdur: FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL). In: Oncologist. Band12, Nr.8, 2007, S.991–998, doi:10.1634/theoncologist.12-8-991.
World Health Organization: World Health Organization model list of essential medicines: 21st list 2019. WHO/MVP/EMP/IAU/2019.06. World Health Organization, 2019 (englisch, who.int [abgerufen am 11. Juli 2021]).